Sugi

SUGI PHARMACY will release figures for the quarter ended February 28, 2026 on April 9, 2026. Three analysts expect an average EPS of 17.45 JPY (prior year: 36.65 JPY). Six analysts forecast revenue of 258.54 billion JPY, up 6.22% versus the same quarter last year. For the just-ended fiscal year, seven analysts' average estimates are EPS of 248.14 JPY (prior year: 141.96 JPY) and revenue of 1,008.86 billion JPY (prior year: 878.02 billion JPY). » Więcej na finanzen.net

SUGI PHARMACY will publish the quarter-end balance sheet for the period to November 30, 2025 on January 8. Three analysts expect EPS of JPY 41.86 per share (+26.31% vs. the prior year) and six analysts forecast revenue of JPY 247.85 billion (+12.25% vs. the prior year). For the current fiscal year, consensus estimates are JPY 246.97 earnings per share and annual revenue of JPY 1,009.77 billion. » Więcej na finanzen.net

SUGI PHARMACY is expected to announce results for the most recent quarter on 08.01.2026. Three analysts forecast an average EPS of 41.86 JPY versus 33.14 JPY a year earlier, with average revenue of 246.66 billion JPY versus 220.81 billion JPY. For the current fiscal year, the average estimates from ten analysts are earnings per share of 247.30 JPY (prior year 141.96 JPY) and revenue of 1,009.63 billion JPY (prior year 878.02 billion JPY). » Więcej na finanzen.net